Screener
Geron GERN Research and clinical expenses — R&D
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Geron in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Geron’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:41 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886744-26-000037
| (in millions) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Costs and operating expenses: | ||||
| Cost of goods sold | 9.2 | 1.2 | 10.9 | 2.4 |
| Research and development | ||||
| Research and clinical expenses | 11.1 | 19.8 | 24.1 | 33.5 |
| Chemistry, manufacturing, and control expenses | 9.5 | 1.9 | 10.1 | 3.3 |
| Restructuring charges | (0.1) | — | (0.3) | — |
| Selling, general and administrative | ||||
| Commercial expenses | 21.6 | 18.8 | 38.6 | 36.5 |
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Geron's research and clinical expenses — R&D?
- Geron (GERN) reported research and clinical expenses — R&D of $11.1M in Q2 2026.
- How has Geron's research and clinical expenses — R&D changed year-over-year?
- Geron's research and clinical expenses — R&D decreased by 43.9% year-over-year, from $19.8M to $11.1M.
- What does research and clinical expenses — R&D mean?
- This metric represents the aggregate costs incurred by the company to support the advancement of its clinical-stage drug pipeline, including laboratory research, clinical trial execution, and regulatory development activities. It reflects the capital intensity of the company's core innovation efforts and its commitment to moving therapeutic candidates through the drug development lifecycle. Monitoring these expenses provides insight into the company's investment strategy for future product commercialization and its overall operational burn rate.
Ask your AI about Geron's research and clinical expenses — r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude